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ABSTRACT
Berries have been found to inhibit colon carcinogenesis in animal models, and 
thus represent a potential source of compounds for prevention and treatment of 
colorectal cancer. The mechanistic basis for their effects is not well understood. 
We used human colon carcinoma cells and Min mice to investigate the effects of 
ellagitannin-rich cloudberry (Rubus chamaemorus) extract on cancer cell migration 
and underlying cell signaling. Intrinsic and hepatocyte growth factor (HGF) -induced 
cell motility in human HT29 and HCA7 colon carcinoma cells was assessed carrying 
out cell scattering and scratch wound healing assays using time-lapse microscopy. 
Activation of Met, AKT, and ERK in cell lines and tumors of cloudberry-fed Min mice 
were determined using immunoprecipitation, Western blot and immunohistochemical 
analyses. Cloudberry extract significantly inhibited particularly HGF-induced cancer 
cell migration in both cell lines. Cloudberry extract inhibited the Met receptor tyrosine 
phosphorylation by HGF and strongly suppressed HGF-induced AKT and ERK activation 
in both HT29 and HCA7 cells. Consistently, cloudberry feeding (10% w/w freeze-
dried berries in diet for 10 weeks) reduced the level of active AKT and prevented 
phosphoMet localization at the edges in tumors of Min mice. These results indicate 
that cloudberry reduces tumor growth and cancer cell motility by inhibiting Met 
signaling and consequent activation of phosphatidylinositol 3-kinase/AKT in vitro 
and in tumors in vivo. As the Met receptor is recognized to be a major target in cancer 
treatment, our results suggest that dietary phytochemicals may have therapeutic 
value in reducing cancer progression and metastasis.
INTRODUCTION
Hepatocyte growth factor (HGF) and its receptor 
the Met tyrosine kinase induce multiple cellular responses 
depending on the environmental context, including 
cell motility, survival, proliferation, morphogenesis 
and angiogenesis [1, 2]. Met is frequently activated 
in human cancers and is a target of intensive cancer 
drug development [3]. Mutations of Met are, however, 
rare events in cancer and aberrant activation mostly 
arises from over-expression of the receptor in cancer 
cells and/or increased secretion of HGF from stromal 
mesenchymal cells [1, 4]. Binding of HGF to Met leads to 
dimerization of the receptor and autophosphorylation of 
several tyrosine residues in the C-terminal tail, including 
two tyrosine residues (Y1349 and Y1356) that serve as 
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a docking site for adapter signaling molecules such as 
Grb-2, Gab-1 and Shc [5, 6]. These docking sites activate 
several key cell signaling pathways including Ras-ERK, 
phosphatidylinositol 3-kinase (PI3K)/AKT, phospholipase 
C, Src and STAT3 [4].
In the intestinal tract, HGF is expressed by 
stromal fibroblasts and fibroblasts within the tumor 
microenvironment, whereas the Met receptor is expressed 
by intestinal epithelial cells [7, 8]. Expression of Met is 
increased at all stages of colon carcinogenesis, including 
dysplastic ACF, adenomas and invasive carcinomas 
[8, 9]. Based on the observations that Met expression 
is localized only to stem and progenitor cells in the 
intestinal epithelium [10–12], it has been proposed that 
during tumor formation wild-type Met is over-expressed 
in cells undergoing aberrant differentiation and retaining 
stem cell properties, which drives the tumorigenesis and 
invasive growth [2]. A number of clinical studies have 
associated Met over-expression with advanced stages of 
colon cancer and as a predictor of tumor invasion and 
lymph node metastases [13, 14]. In tumor cell metastasis, 
the unique ability of activated Met to induce cell motility 
and migration is considered to play an important role [1].
Colorectal cancer is one of the leading causes of 
cancer-related deaths in Western societies. So far the 
most promising chemopreventive agents against colon 
cancer are pharmaceuticals with undesirable side-effects 
(e.g. COX2 inhibitors) [15]. New strategies to prevent 
and treat this cancer are therefore required. Berries are a 
good source of anti-carcinogenic compounds and provide 
protection against colon tumorigenesis in experimental 
animal models. For example, freeze-dried black 
raspberries inhibited intestinal tumorigenesis in Apc1638+/- 
and Muc2-/- mouse models of colorectal cancer [16] and 
tumor formation in the colon of AOM-treated rats [17]. An 
anthocyanin mixture from bilberry significantly reduced 
tumor numbers in the Min mouse [18]. Furthermore, the 
cancer-preventive effects of berries have recently been 
tested in humans. Black raspberry powder resulted in 
regression of rectal polyps when administered to familial 
adenomatous polyposis (FAP) patients as suppositories 
[19] and protectively modulated both genetic and 
epigenetic biomarkers in tissues from sporadic colorectal 
cancer patients when given orally [20]. In both studies, 
the treatment period with berries was relatively short and 
it would be meaningful to study berries as an adjuvant 
therapy for longer time periods in future.
We studied the effects of bilberry, lingonberry 
and cloudberry on intestinal tumorigenesis in the Min 
mouse, an animal model carrying a heterozygous 
germline mutation in the Apc tumor suppressor gene, 
similar to human FAP syndrome and the majority of 
sporadic colorectal cancer cases [21]. Even though the 
majority of tumors in the Min mouse develop in the distal 
small intestine and only very few in the colon itself, 
tumor formation follows the well-established adenoma-
carcinoma sequence. We found that all berries resulted in 
significant reduction in tumor numbers [22]. Cloudberry 
(Rubus chamaemorus), also known as bakeapple or baked-
apple berry in Northern America, was by far the most 
potent chemopreventive berry as it was also able to reduce 
tumor growth, resulting in over 60% reduction in intestinal 
tumor burden. Cloudberry occurs naturally throughout the 
Northern hemisphere, including Scandinavia, Canada and 
some of the northern states in the US.
In this study, we investigated the anti-carcinogenic 
activity and underlying molecular mechanisms of 
cloudberry extract by studying its effects on HGF-induced 
cell migration using human HT29 and HCA7 colon 
carcinoma cells in scattering and scratch wound healing 
assays. We found that cloudberry extract potently inhibited 
HGF-induced and Met receptor-mediated cancer cell 
migration and underlying downstream signaling to ERK 
and AKT in vitro. In line with the in vitro observations 
we found that cloudberry reduced AKT activity and 
localization of phosphorylated Met at the edges in 
intestinal tumors in Min mice in vivo.
RESULTS AND DISCUSSION
Cloudberry extract inhibits HGF-induced 
scattering and scratch wound healing of HT29 
and HCA7 colon adenocarcinoma cells
We used scattering and wound healing assays to study 
the effects of cloudberry extract on cancer cell migration 
[23, 24]. We chose two genetically well characterized 
human colon adenocarcinoma cell lines HT29 and HCA7, 
which represent the two main forms of genetic defects in 
colorectal cancer etiology, namely chromosomal instability 
and microsatellite instability. One of the differences between 
the cell lines is in their status of the tumor suppressor 
adenomatous polyposis coli (APC) gene: HT29 cells carry 
two mutated APC alleles whereas HCA7 are wild type for 
APC [25]. This may be important for migration as APC 
mutations are associated with defects in cell migration early 
during experimental colon tumorigenesis [26]. Both cell 
lines still have an epithelial morphology, similar levels of 
Met and responsiveness to HGF. The migration assays were 
carried out by time-lapse microscopy and quantitatively 
analyzed using an open access, high-throughput image-
processing computer platform.
Both cell lines showed large morphological 
changes in response to HGF treatment (40 ng/mL) when 
followed for 16 hours by time-lapse microscopy (Figure 1, 
Supplementary Movies S1 and S2). These morphological 
changes were clearly visible after 4 hours of HGF treatment 
as demonstrated by confocal images of actin filaments in 
HT29 and HCA7 cells (Figure 2). HT29 cells scattered in 
many respects similarly to the well-established scattering 
of MDCK cells which involves cell spreading, dissociation 
of cell-cell adhesions and radial cell migration (Figure 1A 
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Figure 1: Cloudberry extract inhibits HGF-induced cell scattering in colon adenocarcinoma cells. A. HT29 and B. HCA7 
cells were treated either with 40 ng/ml HGF or HGF together with 5 µL/mL cloudberry extract (CL) and followed every 5 min by time-lapse 
microscopy for 16 hours. Time points 0, 8 h and 16 h are shown in this figure and the movies are available in Supplementary Materials 
(Movies S1-S4). C. Scatter areas were analyzed quantitatively every 5 min by determining the percentage of scatter area as compared to 
the area at time 0. Results (mean +/- SEM) from 4 independent experiments for HCA7 cells (P<0.001 (marked with *** in the figure) HGF 
vs. HGF+Cloudberry treatment).
Oncotarget43910www.impactjournals.com/oncotarget
and 2A) [27, 28]. Most HCA7 cells did not lose their cell-
to-cell contacts in response to HGF but cell colonies spread 
enormously in a radial fashion and eventually lost their 
organized structure (Figure 1B and 2B). Nevertheless, 
in both cell lines cloudberry extract clearly inhibited the 
HGF-induced morphological response (Figure 1 and 2, 
Supplementary Movies S3 and S4). In cloudberry-treated 
HCA7 cells, the increase in scatter area after 15 hours of 
HGF treatment was 53% lower than in control cells without 
cloudberry (Figure 1C). There was a significant difference 
Figure 2: Cloudberry extract prevents HGF-induced morphological changes in colon adenocarcinoma cells. 
A. HT29  and B. HCA7  cells on glass cover slips were treated with 40 ng/ml HGF or HGF together with 5 μL/mL cloudberry extract (CL) 
for 0 h, 4 h and 8 h, fixed and stained for actin filaments with FITC-phalloidin and imaged by confocal microscopy. Bars, 25 μm.
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between the control and cloudberry treatments in scatter 
area (HGF vs. HGF+Cloudberry P<0.001; ANCOVA) and 
scattering in time (P<0.001; ANCOVA).
We used scratch wound healing assays as an 
alternative approach to study the effects of cloudberry 
extract on HGF-induced and intrinsic cell migration. HT29 
cells required over 16 h for scratch wound closure (Figure 
3A) which was twice the time HCA7 cells needed (Figure 
3B). Evaluation of the kinetics of wound closure using 
time-lapse images at various time points to determine 
changes in wound area showed that cloudberry extract 
significantly inhibited HGF-induced wound healing in 
HT29 (Figure 3C; HGF vs. HGF+Cloudberry P<0.001) 
and HCA7 cells (Figure 3D; P<0.001). In both cell 
lines, the differences between these treatments were 
also significant when observed in time (Figure 3C and 
3D; P<0.001, ANCOVA), demonstrating that cloudberry 
extract consistently slows down cancer cell migration.
Without HGF stimulation, scratch wound closure 
of HT29 and HCA7 cells took over 24 h. Cloudberry 
extract inhibited intrinsic cancer cell migration measured 
by scratch wound healing without HGF treatment in the 
APC-mutated HT29 cells (Figure 3E; P<0.001 both on 
average and in time) but not in HCA7 cells (Figure 3F). 
As APC has a well-known role in regulating directional 
cell migration in the gut [29] and APC mutations are found 
in the majority of sporadic colorectal cancers [30], further 
studies will be needed to establish whether the difference 
observed in intrinsic cell migration by cloudberry was 
indeed due to APC status or due to differences in other 
signaling pathways between the cell lines. Furthermore, 
this finding demonstrates that the effect of cloudberry in 
HCA7 cells was specific to HGF-induced migration. In 
each cell line, HGF stimulation accelerated scratch wound 
healing with and without cloudberry treatment (in HT29 
cells, HGF vs. no HGF without cloudberry P<0.001 and 
HGF+Cloudberry vs. no HGF+Cloudberry P=0.016; 
in HCA7 cells, HGF vs. no HGF both with and without 
cloudberry P<0.001; all tested by ANCOVA in time). 
Based on these findings, we conclude that scratch wound 
healing in HGF-stimulated HT29 cells with cloudberry 
treatment resembles wound healing in these cells without 
HGF stimulation. Overall, since cell migration is a 
prerequisite for cancer progression and metastasis, our 
results suggest that cloudberry could slow down cancer 
progression by inhibiting cancer cell migration.
Scattering and scratch wound healing in HT29 
and HCA7 cells are dependent on PI3K/AKT 
and ERK activation
It is well-documented that HGF-induced cell 
scattering, migration, and invasion in different cell types 
involves downstream signaling from the Met receptor to the 
activation of PI3K/AKT and Ras/ERK pathways [23, 31–
35]. We confirmed by western blotting for phosphorylated 
forms of AKT and ERK that HGF stimulation of HT29 
and HCA7 cells led to sustained activation of both AKT 
and ERK, both of which increased by 5 min after the 
addition of HGF, reached a maximum level after 1 – 4 h 
and then gradually decreased to nearly basal levels by 16 
h (Figure 4A). HT29 cells showed a biphasic activation of 
ERK, decreasing transiently at 30-60 min after stimulation, 
similar to that reported for HGF-treated mammary rat 
fibroblasts [33]. While there is no clear evidence for why 
ERK activation is biphasic, we suggest this is because of 
cell spreading and scattering (Figure 1), allowing integrin-
induced ERK activation [36]. The PI3K inhibitor LY294002 
and the MEK1 inhibitor U0126 were used to determine 
whether HGF-induced scratch wound closure and scattering 
in HT29 and HCA7 cells were, indeed, dependent on the 
activation of PI3K and ERK pathways. Treatment of cells 
together with HGF and the inhibitors resulted in partial but 
clear inhibition of scratch wound healing (Figure 4B and 4C 
for HT29 cells) and scattering in both cell lines. LY294002 
inhibited HGF-induced AKT activation and U0126 inhibited 
ERK activation, as expected (data not shown).
Cloudberry extract inhibits HGF-induced AKT 
and ERK activation in HT29 and HCA7 cells
We next studied whether the inhibitory effect of 
cloudberry extract on HGF-induced motility is accompanied 
by downregulation of PI3K and ERK pathways. Cloudberry 
extract inhibited HGF-induced phosphorylation of AKT and 
ERK in HT29 and HCA7 cells at 5 to 60 min (Figure 5A 
and 5D). Densitometric analyses and quantification of band 
intensities from three independent experiments revealed 
a maximum of 77% reduction in the ratio of pAKT/
AKT levels (Figure 5B) and 79% reduction of pERK/
ERK (Figure 5C) in HT29 cells, and a maximum of 91% 
reduction of pAKT/AKT (Figure 5E) and 70% reduction 
of pERK/ERK (Figure 5F) in HCA7 cells. Taken together, 
these results demonstrate that HGF-induced cell migration 
in HT29 and HCA7 cells is dependent on the activation 
of the PI3K/AKT and Ras/ERK pathways, both of which 
contribute to HGF/Met-induced invasive growth program 
in cancer cells [4], and that inhibition of the activation of 
these pathways by cloudberry extract explains its restricting 
effects on cancer cell migration. Cloudberry does not affect 
pAKT in the absence of HGF at either 10 min or 60 min, 
but as expected reduces HGF-induced AKT activation 
(Figure 5G). Surprisingly, cloudberry alone slightly 
increases pERK, but nevertheless reduces HGF-induced 
ERK activation. These results show that cloudberry does 
not reduce pERK or pAKT in unstimulated cells.
Cloudberry extract inhibits HGF-induced Met 
receptor activation
We then studied whether cloudberry extract inhibits 
HGF-induced motility of HT29 and HCA7 at the level of 
activation of its receptor Met. Cells were treated with HGF 
and HGF together with cloudberry extract for the indicated 
Oncotarget43912www.impactjournals.com/oncotarget
Figure 3: Cloudberry extract inhibits HGF-induced scratch wound closure both in HT29 and HCA7 colon 
adenocarcinoma cell lines, but without HGF stimulation in HT29 cells only. Monolayers of A. HT29 and B. HCA7 cells were 
scratch wounded and the HGF-stimulated closure of the wounds was monitored every 5 min by time-lapse microscopy (Movies S5-S8 in 
Supplementary Materials). C-F. Wound areas were analyzed quantitatively every 5 min by determining the percentage of remaining wound 
area as compared to the area of the wound at time 0. Results (mean +/- SEM) from 3 independent experiments with HGF stimulation are 
shown for HT29 and HCA7 cells (C and D. P<0.001 (***) HGF vs. HGF+Cloudberry). Without HGF stimulation, cloudberry extract 
(CL) inhibited scratch wound closure in HT29 (E) P<0.001 (***) control vs. cloudberry) but not in F. HCA7 cells (mean +/- SEM from 3 
independent experiments).
Oncotarget43913www.impactjournals.com/oncotarget
times, followed by immunoprecipitation of Met and western 
blotting for tyrosine phosphorylation (Figure 6A and 6C). 
HGF treatment induced tyrosine phosphorylation of Met, 
which was inhibited by cloudberry extract as assessed by 
the reduction in pMet/Met levels in HT29 (Figure 6B; 
P=0.004, HGF vs. HGF+Cloudberry) and HCA7 cells 
(Figure 6D; P=0.036, HGF vs. HGF+Cloudberry). This 
indicates that cloudberry extract reduces HGF-induced 
ERK and AKT activation and cell migration by directly 
inhibiting activation of the Met receptor and therefore 
preventing receptor signaling. It is noteworthy that 
migratory signaling responses detected by global cell 
analysis (western blotting) are transient, because following 
the initial stimulus signals become localized only to the 
cells at the edge of the wound edge or cell colonies, rather 
than in all cells. Indeed, the wound/colony edge cells show 
impaired extension of lamellipodia throughout our 16-hour 
movies (Supplementary Movies S1-S8), indicating that the 
effect of cloudberry extract is not transient on migration.
Given that the effect of cloudberry extract in 
inhibiting HGF signaling is very rapid, acting within 
minutes of addition, it is possible that it acts outside the 
cell to inhibit HGF binding to Met or specifically inhibits 
Met tyrosine kinase activity. The cloudberry extract was 
particularly rich in ellagitannins, which are complex 
derivatives of ellagic acid, but it also contained moderate 
amounts of flavanols and phenolic acids (Table 1). Based on 
previous findings of the inhibitory effect of ellagic acid on 
cell migration [37] and the sheer abundance of ellagitannins 
in the cloudberry extract, we suggest that they are likely 
to cause Met inhibition. Ellagitannins are large molecules 
and therefore not capable of entering the cell, which implies 
that cloudberry extract interferes with the binding of HGF 
to the Met receptor outside the cell. However, cloudberry 
also contains low levels of free ellagic acid which can enter 
and effectively accumulate in Caco-2 intestinal epithelial 
cells [38], and therefore we cannot entirely exclude the 
possibility that cloudberry compounds act inside the cell.
Here we used an unfractionated cloudberry extract 
containing all compounds of the berry. The concentration 
of cloudberry extract in the cell culture medium was 
moderate, and the concentrations of ellagitannins (36 µg/
mL) and total polyphenols (77 µg/mL) were in the same 
range as used in some previous studies [39]. However, 
in the absence of clinical pharmacokinetic data on the 
metabolism of cloudberry ellagitannins in the gut, it is 
difficult to estimate the accurate concentrations likely to 
be reached in the colon lumen in vivo.
Figure 4: PI3K and ERK are required for HGF-induced migration. A. HGF activates AKT and ERK in HT29 and HCA7 
colon adenocarcinoma cells as shown by western blot analysis. B. Scratch wound healing is dependent on PI3K/AKT and ERK activation 
as treating the HT29 cells with the PI3K inhibitor LY294002 (LY) and the MAPKK (MEK) inhibitor U0126 prevents wound closure as 
determined by time-lapse microscopy. C. Wound areas in HGF-stimulated HT29 cells treated with LY294002 (mean from two independent 
experiments), U0126 (one experiment) and without inhibitors (mean from 3 independent experiments) were analyzed quantitatively every 
5 min by determining the percentage of remaining wound area as compared to the area of the wound at time 0.
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Cloudberry inhibits intestinal tumorigenesis and 
AKT activation in tumors of cloudberry-fed Min 
mice
To evaluate anti-carcinogenic effects of cloudberry 
in vivo, Min mice were fed a high-fat non-fiber diet as a 
control or the same diet supplemented with 10% (w/w) of 
freeze-dried cloudberry for ten weeks. The high fat content 
of the diets was chosen to better mimic current human diets 
in Western societies. The experiments have been described 
in detail elsewhere [22]. The mice in the cloudberry 
group produced significantly fewer intestinal tumors than 
the control mice (Figure 7A, P = 0.031; Mann-Whitney 
U-test). In addition, cloudberry feeding resulted in over 
60% reduction in the tumor area (P = 0.003; Figure 7B), 
indicating a strong inhibitory effect on tumor growth.
In this study we analyzed the signaling pathways 
involved in Met activation in adenoma samples from 
the control and cloudberry-fed mice. We analyzed 
pAKT, AKT, pERK and ERK levels by western blotting 
separately in small (<1 mm) and large (>1.5 mm) diameter 
adenomas using a representative tumor sample from each 
mouse in the control (n=9) and cloudberry groups (n=9; 
Figure 7C). The sample per mouse was obtained by 
excising all tumors from the intestine and pooling them 
according to the size category. The resulting bands were 
Figure 5: Cloudberry extract inhibits HGF-induced AKT and ERK activation. A. HT29 and D. HCA7 cells were analyzed 
by SDS-PAGE and western blotting with antibodies against phospho-AKT(Ser473), phospho-ERK, and total AKT and ERK. Quantification 
of western blots of pAKT/AKT (HGF vs. HGF + CL, P=0.03) and pERK/ERK (P=0.05) levels in HT29 B-C. and HCA7 (E-F. P<0.001 
and P=0.018, respectively) cells from 3 independent experiments. G. The effect of cloudberry extract in the absence of HGF Error bars 
indicate SEM.
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Figure 6: Cloudberry extract inhibits tyrosine phosphorylation of the Met receptor in HGF-treated colon 
adenocarcinoma cells. HGF or HGF and cloudberry extract (CL) treated A. HT29 and C. HCA7 cells were lysed, immunoprecipitated 
with antibody against the Met receptor, and immunoblotted with anti-phosphotyrosine antibody (pTyr), followed by immunoblotting 
with anti-Met antibody. Quantification of western blots of pMet/Met levels in HT29 (B. P=0.004 HGF vs. HGF+Cloudberry) and HCA7 
(D. P=0.036) cells from 3-4 independent experiments. Error bars indicate SEM. E. HT29 or HCA7 cells treated with or without HGF for 
30 min were lysed, immunoprecipitated with control IgG or anti-Met antibody, and immunoblotted for anti-phosphotyrosine antibody and 
anti-Met antibody. Blots are representative of 3 independent experiments. MW, molecular weight markers.
Table 1: Concentrations of phenolic compounds in the cloudberry extract (μg/mL) and in the cell culture medium 
(μg/mL)
μg/mL extract μg/mL in cell
culture medium
Ellagic acid 1067 5.3
Ellagitannins 7251 36.3
Hydroxycinnamic acids 1757 8.8
Hydroxybenzoic acids 1177 5.9
Flavanols 3822 19.1
Anthocyanins 3 0.02
Flavonols 238 1.2
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Figure 7: Cloudberry feeding inhibited intestinal tumorigenesis in the Min mouse.  A. The number of tumors and B. the tumor 
area (burden) in cloudberry-fed Min mice (n = 10-12 / group) were decreased in comparison to control-fed mice as reported previously 
[22]. C. Levels of Met, pAKT, AKT, pERK, and ERK in large adenomas (diameter > 1.5 mm), and levels of pAKT, AKT, pERK, and ERK 
in small adenomas (diameter < 1.0 mm) from each mouse in the control (C) and cloudberry-fed (CL) groups were analyzed by western 
blotting. D. The large adenomas from cloudberry-fed mice showed a significant reduction in the relation of pAKT/AKT levels. G. A similar 
but non-significant trend was seen in small adenomas of the cloudberry-fed mice. No significant differences were seen between the control 
and cloudberry groups either in E, H. ERK or in F. Met levels. In box and whiskers plots, a circle indicates an outlier and an asterisk (*) a 
far outlier.
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quantified by densitometric analyses and the ratio between 
the phosphorylated form and total AKT and ERK levels 
was used as a measure of their activation status. Large 
adenomas of cloudberry-fed mice showed a significant 
reduction in the ratio of pAKT/AKT in comparison to 
adenomas from the control mice (Figure 7C and 7D; 
P=0.015, Mann-Whitney U test), and a similar but non-
significant trend was seen in small adenomas (Figure 7C 
and 7G). No differences in ERK activation was found 
either in small (Figure 7H) or large diameter adenomas 
(Figure 7E). We also analyzed total Met levels in large 
adenomas but found no differences between the dietary 
groups (Figure 7C and 7F) even though the variation in 
Met levels was notably smaller in the cloudberry-fed 
group (Figure 7F). As we were not able to reliably 
determine pMet levels in the adenoma by western blotting, 
we utilized paraffin-embedded intestinal tissue samples 
collected from four control and seven cloudberry-fed mice 
to stain pMet and Met by immunohistochemistry (Figure 
8). Adenomas from control mice had a strong positive 
staining of pMet at the edge of tumors (Figure 8A and 
8C) whereas in cloudberry-fed mice pMet predominantly 
localized in the crypt area of the mucosa (Figure 8D; as 
also observed in control mice), not in the adenoma (Figure 
8B). Unlike in human colorectal cancer, in which Met is 
clearly expressed [8], one earlier study [40] found no Met 
Figure 8: pMet is expressed and localized differently in tumors of control-fed and cloudberry-fed mice. A, C. pMet is 
expressed in the edges of tumors of control-fed mice while B, D. only a few cells, probably lymphocytes, express pMet in the tumors of 
cloudberry-fed mice. The expression of total Met is shown for the tumors of E. control-fed and F. cloudberry-fed mice. G, H. Negative 
controls showed no unspecific pMet staining and its amount in the negative control of total Met was very small Bars, 100 μm.
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overexpression in tumors of Min mice and Met levels in 
general were near the detection limit in adult Min mouse 
gut. pMet was not measured, and thus they did not analyze 
Met activity [40].
In line with the effects of cloudberry extract on 
colon adenocarcinoma cells in vitro, cloudberry is likely 
to have a local effect on cellular responses relevant to 
cell invasion at the edge of tumors as demonstrated by 
our pMet results. This would be more relevant for larger 
tumors that are beginning to invade the surrounding 
tissues even though there was a trend for reduced AKT 
activation in small adenomas, indicating that changes 
start occurring during early stages of tumorigenesis. Our 
results suggest that inhibition of the Met and PI3K/AKT 
pathways are involved in mediating the anti-carcinogenic 
effects of cloudberry in vivo. Using Affymetrix microarray, 
we have observed a six-fold increase in HGF expression 
in the normal appearing mucosa of the Min mouse in 
comparison to the mucosa of wild-type C57BL/6J mouse 
(unpublished observation), indicating a role of HGF/
Met signaling in intestinal tumor development in the 
Min mouse, similar to human studies. Importantly, a 
recent study demonstrated that stromal-derived HGF and 
consequent Met activation is needed to maintain stem cell-
like properties of colon cancer cells through activation of 
Wnt-β-catenin-dependent transcription [41], suggesting 
an active role for tumor microenvironment and HGF/
Met signaling possibly early on in the development of 
colorectal cancer. As dietary factors have been shown to 
alter the activity of both Wnt and Met pathways [22, 42], 
regulating the tumor microenvironment by dietary means 
provides an intriguing target for cancer prevention.
CONCLUSIONS
Our results with the Min mouse demonstrate that 
cloudberry is able to inhibit the early stages of colon 
carcinogenesis [22]. This mouse strain is the most 
widely used animal model for colon cancer studies, but 
it does not measure metastasis, since metastases do not 
form. Our results with colon carcinoma cells may better 
predict the capacity of cloudberry to inhibit later stages 
of colon carcinogenesis, when cancer cells become more 
invasive. Indeed, we show here using cell scattering and 
scratch wound healing assays that cloudberry extract 
strongly inhibits HGF-induced and Met receptor-
mediated cancer cell migration, a prerequisite for 
cancer cells to metastasize. Significantly, we also 
demonstrate that this is mediated by cloudberry’s ability 
to inhibit the phosphorylation and thus activation of the 
Met receptor and its downstream activation of both 
PI3K/AKT and ERK pathways. Since these pathways 
are known to drive the invasive growth program in 
cancer cells [4], cloudberry extract could act to slow 
cancer progression and spreading. As the Met receptor 
is recognized to be one of the major therapeutic targets 
of the hallmarks of cancer [43], dietary phytochemicals 
acting as natural HGF/Met inhibitors are likely to have 
therapeutic value in preventing cancer invasion and 
metastasis.
We suggest that the chemopreventive effects of 
cloudberry are mainly due to ellagitannins, the main 
class of its polyphenols, even though it also contains 
flavanols, organic acids and some free ellagic acid. It is, 
however, possible that synergistic effects of the phenolic 
compounds occur and they together may exert a stronger 
chemopreventive effect than any of the compounds alone 
[39]. Major ellagitannins in cloudberry are sanguiin H6, 
sanguiin H10 and lambertinian C [44]. A similar profile 
of ellagitannins is found in raspberries, while other good 
sources of ellagitannins include blackberry, arctic bramble, 
strawberry, pomegranate, certain nuts, and oak-aged wines 
[44, 45]. Of these, pomegranate is the most studied source 
of ellagitannins, which together with ellagic acid and its 
metabolites, have previously been shown to have anti-
carcinogenic activity in cell cultures and animal models 
[46]. Pomegranate ellagitannins have recently been 
studied in clinical trials for treatment of prostate cancer 
[47]. So far, an effect of berries in cancer treatment has 
been tested for black raspberry in two phase 1 studies in 
FAP and colorectal cancer patients with promising results 
[19, 20], and our results suggest that cloudberry should 
also be tested in the future.
In summary, we show here that cloudberry extract 
inhibits HGF-induced scattering and migration into a 
scratch wound in HT29 and HCA7 colon adenocarcinoma 
cells, which is accompanied by inhibition of Met receptor 
activation and downstream signaling to the PI3K/AKT 
and ERK pathways. Furthermore, we found that AKT 
activation and localization of pMet on tumor edges was 
reduced in large adenomas from cloudberry-fed Min 
mice compared to control mice. We have previously 
reported that cloudberry feeding results in inhibition of 
nuclear accumulation of β-catenin and cyclin D1 in the 
Min mouse tumors as well as reduction in expression of 
e.g. prostaglandin E receptor subtype EP4 in the normal 
appearing mucosa [22], so presumably there are several 
mechanisms contributing to the inhibitory effect of 
cloudberry on tumorigenesis. Taken together, these results 
suggest that cloudberry and its compounds possess strong 
chemopreventive activity against colon cancer which is 
at least partly mediated through the inhibition of the Met 
receptor and downstream signaling to the PI3K pathway.
MATERIALS AND METHODS
Reagents and antibodies
Human fibronectin, U0126 and fluorescein 
isothiocyanate(FITC)-conjugated phalloidin were 
purchased from Sigma-Aldrich (Gillingham, UK), 
LY294002 from Merck, recombinant human HGF from 
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R&D Systems (Abingdon, UK), antibodies against 
pAKT [Ser473], AKT and pERK from Cell Signaling 
Technology, ERK1 (K-23), Met (C-12, SP260), protein 
A/G PLUS-agarose were from Santa Cruz Biotechnology 
(Santa Cruz, CA), and Immobilon P membrane from 
Millipore.
Preparation of cloudberry extract for cell culture 
studies
Six grams of freeze-dried cloudberries were crushed 
(including the seeds and peels) and extracted twice with 
25 mL of methanol by vortexing for 1 min followed by 
centrifugation for 10 min at 3500g. The supernatants 
were combined and methanol was removed by rotary 
evaporation at 30ºC under vacuum. The semidried sample 
was reconstituted in 4.5 mL of Milli-Q water and frozen. 
Two independent preparations of cloudberry extract were 
used in the study. The phenolic profile of cloudberry 
extract was analyzed as described below and the 
concentrations of phenolic compounds in the cloudberry 
extract and cell culture medium are shown in Table 1.
UPLC analysis of phenolic profile of cloudberry 
extract
Preparation of extract from freeze-dried cloudberries 
followed the same procedure as for the cell culture 
studies. The final cloudberry extract was dissolved in 
20% methanol, and filtered with 0.2 μm syringe filters 
prior to analysis. The phenolic profile of berry extract 
was determined according to the method described earlier 
[48] using Waters ACQUITY ultra performance liquid 
chromatography (UPLC) coupled with eλ photodiode 
array (PDA) and fluorescence (FLR) detectors. The 
column used was a Waters HSS T3 C18, 1.7 μm, 2.1 x 
150 mm, with 5 μL injection volume, and separation was 
achieved using a gradient program with water/0.5% formic 
acid and acetonitrile/0.5% formic acid with a constant 
flow rate of 0.5 mL/min. Samples were analysed in 
triplicate with double injections. Identification of phenolic 
compounds was based on their UV spectra, and phenolics 
were clustered into seven subclasses: ellagic acids, 365 nm 
and ellagitannins as ellagic acids, 280 nm; anthocyanins 
as cyanidin-3-glucosides, 520 nm; flavonols as rutin, 365 
nm; hydroxycinnamates as chlorogenic acid, 320 nm; 
hydroxybenzoates as gallic acid, 280 nm; catechins and 
flavan-3-ols as procyanidin B2, FLR.
Cell culture
The HT29 (purchased from American Type 
Culture Collection for this study) and HCA7 human 
colon adenocarcinoma cells (kindly provided and 
authenticated by Walter Bodmer, University of Oxford; 
[49]) were cultured at 37°C in a 5% CO2 atmosphere in 
DMEM (Gibco-Invitrogen) supplemented with 10% FCS, 
penicillin and streptomycin. For all experiments, cells were 
seeded on fibronectin-coated (10 µg/mL) tissue culture 
dishes. The concentration of cloudberry extract applied 
to cells was chosen based on preliminary experiments 
where the effects of concentrations ranging between 0 - 
20 μL/mL were tested on cells for 24 - 48 h. The chosen 
concentration of 5 μL/mL did not result in reduction in 
cell numbers nor induce cell necrosis as assessed using a 
hemocytometer and trypan blue staining (data not shown).
Analysis of cell migration using time-lapse 
microscopy
For cell scattering experiments, HT29 (3x104/mL) 
and HCA7 (6x104/mL) cells were seeded on fibronectin-
coated dishes containing a 13-mm glass coverslip in 
the center and incubated for 48 - 72 h before time-lapse 
microscopy. Cells were treated either with 40 ng/mL HGF 
or HGF together with 5 µL/mL of cloudberry extract in 
growth medium. Cloudberry extract was applied to cells 
30 min before HGF. During the time-lapse experiments 
cells were incubated at 37°C in a humidified chamber 
at 5% CO2. Phase-contrast images of live cells were 
collected every 5 min for 16 hours with Tempus software 
(Andor Technology, Belfast, UK), using a KPM1E/K-S10 
CCD camera (Hitachi, Denshi, Japan) mounted on an 
Axiovert microscope using a 20X Plan/Neofluar objective 
(Zeiss). For wound healing experiments, cells were seeded 
at high density on fibronectin-coated 35-mm-diameter 
tissue culture plastic dishes and allowed to grow to 100% 
confluence. Cells were washed twice with PBS (phosphate 
buffered saline) without calcium and magnesium (Gibco-
Invitrogen), scratch wounded with a 10 µL pipette tip, 
rinsed twice with medium and treated either with 40 ng/
mL HGF or HGF together with 5 µL/mL of cloudberry 
extract in growth medium. Wound closure was monitored 
by time-lapse microscopy as described for cell scattering 
experiments.
Quantification of wound and scatter areas in 
time-lapse images
Wound healing images were analyzed quantitatively 
at various time points by determining the percentage 
of remaining wound area as compared to the area of 
the wound at the first time point. The wound area at 
each time point was measured with the geodesic active 
contours [50] by setting a few initial circular contours 
in the middle of the wound, and making the contours 
iteratively propagate to fill the whole wound area. As the 
active contours can merge and split during the iterative 
process, final area was defined by the outermost contour 
to exclude effect of all inner contours formed especially 
in cloudberry images. All processing was carried out with 
BioImageXD software, an open access, high-throughput 
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image-processing computer platform [51]. The scatter 
area evolution was measured as wound area except 
only the single initial contour, which included whole 
scatter area, was used. The contour was made to contract 
during iterations after which the area was defined as a 
combination of all isolated contours generated during 
the contraction of the initial contour. All contours were 
included in area analyses at all the time points as these 
merged to one larger area during the experiment.
Whole cell extracts and western blot analyses
HT29 (3x104/mL) and HCA7 (6x104/mL) cells were 
seeded on fibronectin-coated tissue culture plastic and 
incubated for 48-72 h. Cells were treated either with 40 
ng/mL HGF or HGF and 5 μg/mL of cloudberry extract 
in serum-free (HT29) or low-serum (HCA7) DMEM for 
the indicated times. Cells were washed twice with ice-cold 
PBS and lysed for 10 minutes on ice in lysis buffer (50 
mmol/L Tris-HCl (pH 7.4), 150 mmol/L NaCl, 1 mmol/L 
EDTA, 1% Triton X-100, 1 mmol/L PMSF, 10 μg/mL 
leupeptin, 2 μg/mL aprotinin, 1 mmol/L dithiothreitol, 
1 mmol/L NaF, and 0.2 mmol/L Na3VO4). Lysates were 
clarified by centrifugation at 14 000 x g for 10 min at 4°C. 
Protein concentrations were determined using BioRad 
Bradford protein assay reagent. Lysates were denatured 
in Laemmli sample buffer and heated at 98°C for 5 min. 
Twenty μg of protein from the extracts was resolved on 
10% SDS-PAGE and transferred to PVDF membrane 
(Immobilon P, Millipore). Membranes were blocked in 5% 
bovine serum albumin (pAKT, pERK) or 5% non-fat milk 
(AKT, ERK) in Tris-buffered saline and 0.1% Tween-20 
for 1 h and probed with primary antibodies overnight at 
4°C (pAKT and pERK) or for 2 h at room temperature 
(AKT, ERK). After extensive washing, membranes 
were incubated with horseradish-peroxidase-conjugated 
secondary antibody for 1 h at room temperature and 
developed using enhanced chemiluminescence kit 
(Amersham/GE Healthcare, UK). Band intensities were 
determined and quantified using a GS-800 densitometer 
and Quantity One software (BioRad, Hercules, CA). Blots 
were stripped between determination of phosphorylated 
and total protein levels for AKT and ERK. Small diameter 
(<1 mm) and large diameter (>1.5 mm) adenomas of Min 
mice were collected separately and analyzed for Met, 
pAKT, AKT, pERK, and ERK as described above.
Immunoprecipitation
Cells were seeded on 100-mm-diameter fibronectin-
coated tissue culture dishes, grown to semi-confluency, and 
treated either with HGF or HGF and cloudberry extract. 
Cell lysates were prepared as described above except that 
cells were lysed with 1000 μL of lysis buffer per sample, 
containing 10% of glycerol. 250 μg of protein from the 
lysates were incubated with 25 μL of anti-Met antibody 
conjugated to protein A/G PLUS-agarose (Santa Cruz) for 
4 h at 4°C. The pellets were collected by centrifugation at 
1000 x g and washed four times for 5 min each with lysis 
buffer at 4°C. The pellets were resuspended in 30 μL of 
Laemmli sample buffer, heated at 98°C for 5 min, resolved 
on 7.5% SDS-PAGE and transferred to PVDF membrane. 
The blots were probed with anti-phosphotyrosine antibody 
(Clone 4G10, Upstate), followed by stripping and probing 
for total Met levels with anti-Met antibody (Santa Cruz). 
The blots were developed and bands quantified as 
described above.
Actin staining for confocal microscopy
HT29 and HCA7 cells were seeded on fibronectin-
coated glass coverslips, incubated and treated with HGF 
and cloudberry extract as described above. Cells were fixed 
in 4% paraformaldehyde in PBS for 20 min, permeabilized 
in 0.2% Triton-X-100 for 5 min, and stained with FITC-
conjugated phalloidin to visualize actin filaments. Cells 
were mounted in Dako fluorescent mounting medium 
(DAKO, Ely, UK). Images were collected with LSM510 
software, using a confocal laser scanning microscopy 
(LSM510, Carl Zeiss, Welwyn Garden City, UK) and a 
40X/1.3 NA Plan Neofluar objective.
Animals and diets
The Laboratory Animal Ethics Committee of the 
University of Helsinki, Finland, approved the study 
protocol. Research was done complying with good 
laboratory practice, including national and institutional 
guidelines for the care and use of animals. Male and 
female C57BL/6J-ApcMin/J (Min) mice (n=10-12/group) 
were fed AIN93-based high-fat control diet or the 
same diet supplemented with 10% (w/w) freeze-dried 
cloudberry for ten weeks as described previously [22]. 
The high fat content (20% w/w corresponding 40% of 
energy intake) of the diets was chosen to better mimic 
current human diets in Western societies. The number and 
size of intestinal adenomas were determined blind by two 
observers, using a dissecting microscope connected to a 
screen with magnification of 67 by two observers blind 
to treatment. Tumors were excised, snap frozen in liquid 
nitrogen and stored at -70°C until further analyses.
Immunohistochemical staining
Paraffin tissue sections were deparaffinized and 
subjected to heat-induced antigen retrieval in microwave 
oven for 15 min at 800W power in 250 ml of citrate 
buffer (pH 6.0), followed by a 20 min cooling period. 
Immunostaining with anti-Met (c-Met, ab59884; 1:400), 
anti-phospho-Met (ab5662, c-Met, phospho-Y1230 + 
Y1234 + Y1235; 1:1500) (both antibodies from Abcam, 
Cambridge, UK), and counterstaining with Mayer’s 
hemalaum (Merck) were performed using UltraVision 
Quanto Mouse on Mouse HRP detection kit (LabVision/
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Thermo Fisher Scientific, Cheshire, UK) for Met, 
and BrightVision Poly-HRP-anti rabbit detection kit 
(Immunologic, Duiven, Netherlands) for phospho-Met. 
Negative control tissues were prepared similarly, except 
the primary antibody was replaced with normal antibody 
diluent (Immunologic, Duiven, Netherlands) for anti-Met 
and diluent containing 10% goat serum for anti-phospho-
Met. The immunostained sections were imaged using a 
Leica DM4000 microscope (Wetzlar, Germany) and an 
Olympus DP70 camera (Tokyo, Japan).
Statistical analyses
Statistical analyses were carried out using StatView 
5.0.1 (SAS Institute Inc., Cary, NC) and PASW 18.0.1 
(SPSS Inc., 2009, Chicago, IL) softwares. Differences 
of standardized wound and scatter-data behavior in 
treatment groups (HGF vs. HGF + cloudberry) in time 
were compared with parametric ANCOVA (group*time) 
interaction terms. The binary presence of HGF and type 
of cell (HCA7 and HT29) was also used as a stratifying 
variable, or as a group variable instead of cloudberry 
treatment in the analyses. Linear fit was utilized; it suited 
the data set best both statistically and contextually. The 
western blot results were analyzed by Mann-Whitney 
U test and differences were considered significant at 
P < 0.05.
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